Development of an adverse outcome pathway for chemically induced hepatocellular carcinoma: case study of AFB1, a human carcinogen with a mutagenic mode of action

Martha M. Moore, Rita S. Schoeny, Richard A. Becker, Kimberly White, Lynn H. Pottenger
  • Critical Reviews in Toxicology, February 2018, Taylor & Francis
  • DOI: 10.1080/10408444.2017.1423462

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1080/10408444.2017.1423462

In partnership with: